METHOD FOR SELECTION OF MOST EFFECTIVE ANTIARRHYTHMIC DRUG FOR PATIENTS WITH EXTRASISTOLY Russian patent published in 2018 - IPC A61B5/402 

FIELD: medicine.

SUBSTANCE: patient with extrasystole receives anti-arrhythmic drugs to be tested one after the other. Each subsequent drug is administered after 3-5 half-lives of the previous one. Before and after the onset of the action of the antiarrhythmic drug studied, which is defined as the half-life of its half-life, an ECG study is performed. At that, linear deviation of corrected pre-ectopic interval separately for left and right sided ventricular extrasystole, supraventricular extrasystole not less than in 20 extrasystoles. Then the extrasystole index is calculated using the formula and with the maximum increase of the extrasystole index, compared to the baseline values, the studied antiarrhythmic drug is defined as the most effective.

EFFECT: method provides a significant reduction in the time of drug selection in each case of extrasystole treatment.

4 ex, 12 tbl